Fact Sheet: Channel Catfish Pituitary INAD 11-468

for detailed information, see INAD study protocol, use link on the left
last updated: 1 December 2011

The following links are specific to:
Channel Catfish Pituitary

Drug summary & history

List of FDA-Approved drugs

Drug forms to be completed

Examples of completed forms

INAD study protocol

Material Safety Data Sheet
(MSDS)

Study summaries

What's the status of this drug's
approval

Print this drug fact sheet

Print all drug fact sheets

Sign-up via the INAD Program Management System (IPMS)

Information on EPA's National Pollutant Discharge Elimination System (NPDES) Permits

Authorization & Categorical Exclusion Letters

Objective/purpose: Collect scientific data necessary to establish the efficacy of Channel Catfish Pituitary (CP) on gamete maturation in a variety of catfish species.
Drug name: Channel Catfish Pituitary
Source of drug:

Hybrid Catfish Company

Address: 1233 Montgomery Drive
Inverness, MS 38753
Phone: 662-265-5308
Contact: Attn: Roger Yant
Phone: 662-265-5308
FAX: 662-207-0461
email: yant@telepak.net.
Target pathogen(s): Not applicable
Method of administration: IP or IM injection in sterile saline
Treatment dosage:

Up to 25 mg per kg body weight within a 12 hour period

Although certain situations may require a higher dosage rate, dosage will never exceed 25 mg CP/kg body weight

Treatment regimen:

1 or 2 treatments total within a 12 hour period. A dual treatment will generally consist of a single “priming dose”, followed by a single “resolving dose."

Withdrawal period:

3 days

No withdrawal period is required for treated fish that will not be susceptible to legal harvest for 3 days post-treatment.

No withdrawal period is required for offspring of fish receiving channel catfish pituitary.

Required test parameters: Investigator must collect data reporting percent ovulation and/or percent spermiation in treated fish. Investigator should also report general fish behavior and any possible adverse effects relating to treatment.
Limitations or restrictions on use:

Investigator must follow all instructions in the Study Protocol for INAD 11-468 regarding drug acquisition and handling, fish treatment and disposition, and data reporting requirements.

Required INAD fee: $400.00 per facility per year
AADAP contact for other information: Ms. Bonnie Johnson, FWS - AADAP
Phone: 406-994-9905
Fax: 406-582-0242

bonnie_johnson@fws.gov
Disclaimer: Product and company names mentioned in this website, or mentioned in materials accessed via this website, are for informational purposes only. The mention of such does not imply endorsement by the Aquatic Animal Drug Approval Partnership, the U.S. Fish & Wildlife Service or any other organization of the U.S. Government.